SENS Fundamental Analysis - SENSEONICS HOLDINGS INC

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to SENS. SENS was compared to 191 industry peers in the Health Care Equipment & Supplies industry. While SENS seems to be doing ok healthwise, there are quite some concerns on its profitability. SENS is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

SENS had negative earnings in the past year.

SENS had a negative operating cash flow in the past year.

In the past 5 years SENS reported 4 times negative net income.

SENS had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

SENS's Return On Assets of -45.39% is on the low side compared to the rest of the industry. SENS is outperformed by 63.87% of its industry peers.

With a Return On Equity value of -72.01%, SENS perfoms like the industry average, outperforming 41.88% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-45.39%
ROE	-72.01%
ROIC	N/A

ROA(3y)-13.99%

ROA(5y)-136.34%

ROE(3y)-16.55%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Gross Margin of SENS (17.77%) is worse than 80.63% of its industry peers.

SENS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	17.77%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

SENS does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, SENS has more shares outstanding

The number of shares outstanding for SENS has been increased compared to 5 years ago.

The debt/assets ratio for SENS is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -4.37, we must say that SENS is in the distress zone and has some risk of bankruptcy.

The Altman-Z score of SENS (-4.37) is worse than 68.59% of its industry peers.

SENS has a Debt/Equity ratio of 0.37. This is a healthy value indicating a solid balance between debt and equity.

SENS has a Debt to Equity ratio of 0.37. This is comparable to the rest of the industry: SENS outperforms 48.69% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.37
Debt/FCF	N/A
Altman-Z	-4.37

ROIC/WACCN/A

WACC8.64%

2.3 Liquidity

A Current Ratio of 9.58 indicates that SENS has no problem at all paying its short term obligations.

SENS has a better Current ratio (9.58) than 91.10% of its industry peers.

A Quick Ratio of 9.26 indicates that SENS has no problem at all paying its short term obligations.

The Quick ratio of SENS (9.26) is better than 92.15% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	9.58
Quick Ratio	9.26

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

SENS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 23.08%, which is quite impressive.

SENS shows a small growth in Revenue. In the last year, the Revenue has grown by 5.94%.

Measured over the past years, SENS shows a small growth in Revenue. The Revenue has been growing by 1.08% on average per year.

EPS 1Y (TTM)23.08%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%33.33%

Revenue 1Y (TTM)5.94%

Revenue growth 3Y18.01%

Revenue growth 5Y1.08%

Sales Q2Q%36.67%

3.2 Future

SENS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.87% yearly.

Based on estimates for the next years, SENS will show a very strong growth in Revenue. The Revenue will grow by 50.14% on average per year.

EPS Next Y35.65%

EPS Next 2Y12.76%

EPS Next 3Y10.16%

EPS Next 5Y14.87%

Revenue Next Year62.85%

Revenue Next 2Y67.67%

Revenue Next 3Y63.72%

Revenue Next 5Y50.14%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

SENS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year SENS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y12.76%

EPS Next 3Y10.16%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

SENS does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

SENSEONICS HOLDINGS INC

NYSEARCA:SENS (10/7/2025, 9:59:03 AM)

0.4847

-0.08 (-14.21%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)08-06 2025-08-06/amc

Earnings (Next)11-05 2025-11-05/amc

Inst Owners18.56%

Inst Owner Change0%

Ins Owners2.78%

Ins Owner Change5.2%

Market Cap394.88M

Analysts76.92

Price Target1.46 (201.22%)

Short Float %6.7%

Short Ratio8.75

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)8.35%

Min EPS beat(2)1.96%

Max EPS beat(2)14.75%

EPS beat(4)3

Avg EPS beat(4)9.2%

Min EPS beat(4)-14%

Max EPS beat(4)34.09%

EPS beat(8)6

Avg EPS beat(8)7.97%

EPS beat(12)7

Avg EPS beat(12)-0.74%

EPS beat(16)11

Avg EPS beat(16)63.45%

Revenue beat(2)2

Avg Revenue beat(2)9.27%

Min Revenue beat(2)8.25%

Max Revenue beat(2)10.29%

Revenue beat(4)4

Avg Revenue beat(4)6.13%

Min Revenue beat(4)2.48%

Max Revenue beat(4)10.29%

Revenue beat(8)7

Avg Revenue beat(8)5.36%

Revenue beat(12)10

Avg Revenue beat(12)4.93%

Revenue beat(16)11

Avg Revenue beat(16)2.84%

PT rev (1m)1.24%

PT rev (3m)-28.5%

EPS NQ rev (1m)0%

EPS NQ rev (3m)8.35%

EPS NY rev (1m)-0.95%

EPS NY rev (3m)20.03%

Revenue NQ rev (1m)-1.73%

Revenue NQ rev (3m)-9.43%

Revenue NY rev (1m)-0.34%

Revenue NY rev (3m)1.76%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	15.51
P/FCF	N/A
P/OCF	N/A
P/B	4.17
P/tB	4.2
EV/EBITDA	N/A

EPS(TTM)-0.1

EYN/A

EPS(NY)-0.09

Fwd EYN/A

FCF(TTM)-0.07

FCFYN/A

OCF(TTM)-0.07

OCFYN/A

SpS0.03

BVpS0.12

TBVpS0.12

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-45.39%
ROE	-72.01%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	17.77%
FCFM	N/A

ROA(3y)-13.99%

ROA(5y)-136.34%

ROE(3y)-16.55%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score5

Asset Turnover0.17

Health

		Industry Rank	Sector Rank
Debt/Equity	0.37
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	22.67%
Cap/Sales	1.53%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	9.58
Quick Ratio	9.26
Altman-Z	-4.37

F-Score5

WACC8.64%

ROIC/WACCN/A

Cap/Depr(3y)70.29%

Cap/Depr(5y)48.74%

Cap/Sales(3y)4.48%

Cap/Sales(5y)3.72%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)23.08%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%33.33%

EPS Next Y35.65%

EPS Next 2Y12.76%

EPS Next 3Y10.16%

EPS Next 5Y14.87%

Revenue 1Y (TTM)5.94%

Revenue growth 3Y18.01%

Revenue growth 5Y1.08%

Sales Q2Q%36.67%

Revenue Next Year62.85%

Revenue Next 2Y67.67%

Revenue Next 3Y63.72%

Revenue Next 5Y50.14%

EBIT growth 1Y11.96%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year20.93%

EBIT Next 3Y12.25%

EBIT Next 5YN/A

FCF growth 1Y21.67%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y22.05%

OCF growth 3YN/A

OCF growth 5YN/A

SENSEONICS HOLDINGS INC (SENS) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens